French public and advertising giant Publicis Groupe — the lead funder of “disinformation watchdog” NewsGuard — has agreed to pay $350 million as part of a settlement with state attorneys general over the company’s role in America’s opioid crisis. “Today’s filings describe how Publicis’ work contributed to the crisis by helping Purdue Pharma and other opioid manufacturers market and sell opioids,” said a press release from South Carolina Attorney General Alan Wilson. “Court documents detail how Publicis acted as Purdue’s agency of record for all its branded opioid drugs, including OxyContin, even developing sales tactics that relied on farming data from recordings of personal health-related in-office conversations between patients and providers.” “The company was also instrumental in Purdue’s decision to market OxyContin to providers on patient’s electronic health records,” said the press release. At the same time it is paying this $350 million settlement over its marketing tactics — Publicis Groupe, headed by CEO and Chairman Arthur Sadoun (pictured above) is also the “largest corporate investor” in NewsGuard, a company whose co-founder said it is a “vaccine against misinformation,” reported Lee Fang in RealClearInvestigations. NewsGuard said it “provides transparent tools to counter misinformation” and in 2021, it announced a partnership with Publicis to “combat…
Read the full storyPR Group Behind ‘Watchdog’ NewsGuard Hit with $350 Million Settlement over OxyContin Marketing
